UK Markets close in 7 hrs 49 mins

Medacta Group SA (0A05.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
96.50-1.24 (-1.27%)
As of 06:19PM BST. Market open.
Full screen
Previous close97.74
Open97.00
Bid0.00 x N/A
Ask0.00 x N/A
Day's range96.30 - 97.70
52-week range96.30 - 97.70
Volume622
Avg. volumeN/A
Market cap1.938B
Beta (5Y monthly)1.30
PE ratio (TTM)32.54
EPS (TTM)2.97
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Medacta Group SA reports 19.0% growth of half-year revenue

    Medacta Group SA / Key word(s): Sales Result29-Jul-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Press Release – Ad-hoc announcement pursuant to Art. 53 LR Medacta Group SA reports 19.0% growth of half-year revenue 1H 2022 revenue increased to Euro 211.3 million, or 19.0% reported (14.6% at constant currency1) from 1H 2021 Significant customer acquisition, salesforce expansion and product introdu

  • EQS Group

    Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia

    Medacta Group SA / Key word(s): Product LaunchMedacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia 23.06.2022 / 19:00 Media release Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in AustraliaCASTEL SAN PIETRO, Switzerland, 23 June 2022 – Medacta announces the first lumbar fusion procedure in Australia utilizing the M.U.S.T.® Pedicle Screw System in combination with NextARTM Spine, the first C

  • Simply Wall St.

    Shareholders in Mayne Pharma Group (ASX:MYX) are in the red if they invested five years ago

    It is doubtless a positive to see that the Mayne Pharma Group Limited ( ASX:MYX ) share price has gained some 36% in...